MEC Practice Academy 11.19

Spotlight -

Concierge Medicine Forum|

Practice Finance

CME Content

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Please check back later for more content.

Trending on Medical Economics

10 hidden costs of switching EHRs

'You're willing to help the team, but only for so long': What rural physicians need to stay

Patients would rather wait for a clinician’s review than get an instant AI answer to medical questions

Why health plans should rethink GLP-1 coverage

Medicare’s MIPS program: 10 years, 200 hours a year and a 1% tip